Anti-oxidized low-density lipoprotein antibodies in chronic heart failure

• Published in: World journal of cardiology Vol. 4; no. 11; pp. 302 - 308
• Main Authors: Charach, Gideon, Rabinovich, Alexander, Argov, Ori, Weintraub, Moshe, Charach, Lior, Ayzenberg, Oded, George, Jacob
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Co., Limited 26-11-2012
• Subjects: Antibodies; Antioxidants; failure; Heart; lipoproteins; low-density; Oxidized; Antioxidants; Heart failure; Antibodies; Oxidized low-density lipoproteins
• ISSN: 1949-8462; 1949-8462
• DOI: 10.4330/wjc.v4.i11.302

Oxidative stress may play a significant role in the pathogenesis of heart failure(HF).Antibodies to oxidized low-density lipoprotein(oxLDL Abs) reflect an immune response to LDL over a prolonged period and may represent long-term oxidative stress in HF.The oxLDL plasma level is a useful predictor of mortality in HF patients,and measurement of the oxLDL Abs level may allow better management of those patients.Antibodies to oxLDL also significantly correlate with the New York Heart Association score.Hypercholesterolemia,smoking,hypertension,and obesity are risk factors for atherosclerotic coronary heart disease(CHD) leading to HF,but these factors account for only onehalf of all cases,and understanding of the pathologic process underlying HF remains incomplete.Nutrients with antioxidant properties can reduce the susceptibility of LDL to oxidation.Antioxidant therapy may be an adjunct to lipid-lowering,angiotensin converting enzyme inhibition and metformin(in diabetes) therapy for the greatest impact on CHD and HF.Observational data suggest a protective effect of antioxidant supple-mentation on the incidence of HD.This review summarizes the data on oxLDL Abs as a predictor of morbidity and mortality in HF patients.